[Retracted] Ovarian Cancer Risk Scores Based on Immune-Related Pseudogenes to Predict Overall Survival and Guide Immunotherapy and Chemotherapy

<div>Performance of the irPseus pair signature for prognosis prediction. (a) The 10-irPseus pair model and its risk score distribution status and (b) patients survival outcome status. (c) Individuals in the high-risk subgroup presented a shorter OS revealed by the Kaplan–Meier test.</div>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: [Retracted] Ovarian Cancer Risk Scores Based on Immune-Related Pseudogenes to Predict Overall Survival and Guide Immunotherapy and Chemotherapy 

Figure 4 | [Retracted] Ovarian Cancer Risk Scores Based on Immune-Related Pseudogenes to Predict Overall Survival and Guide Immunotherapy and Chemotherapy 